Frontlight ResearchEarly access
Trial site
Liverpool
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Coronary artery disease2 trials
- Sjögren's disease2 trials
- Stroke2 trials
- Aortic stenosis1 trial
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- Epilepsy1 trial
- Familial hypercholesterolaemia1 trial
- Glioblastoma1 trial
- Neuroblastoma1 trial
- and 2 more
- Phase
- Phase 25 trials
- Phase 35 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed3 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals12 trials
- Advanced Accelerator Applications1 trial
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 13 Nov 2026